NCT00256282 Docetaxel and Vinorelbine Plus Sargramostim in Metastatic Malignant Melanoma Status COMPLETED Phase PHASE2
NCT00235235 A Correlative Study for Predicting Response and Toxicity in Patients Receiving Chemotherapy for Breast Cancer Status TERMINATED Phase N/A
NCT00225173 Combination Chemotherapy +/- Radiation in High Risk Hodgkin's Disease Status TERMINATED Phase PHASE2
NCT00215930 The 'MADe IT' Clinical Trial: Molecular Analyses Directed Individualized Therapy for Advanced Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00215462 Vinorelbine in Unresectable or Metastatic Esophageal and Gastric Adenocarcinoma Status COMPLETED Phase PHASE2
NCT00194740 Taxotere Plus Weekly Navelbine and G-CSF: A Study in Stage IV Breast Cancer Status COMPLETED Phase PHASE2
NCT00194727 Weekly Vinorelbine and Oral Capecitabine as Treatment for Stage IV Breast Cancer Status COMPLETED Phase PHASE2
NCT00193362 Study of Paclitaxel, Carboplatin, and Gemcitabine Versus Gemcitabine and Vinorelbine for Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE3
NCT00193089 Docetaxel, Vinorelbine and Trastuzumab in the Treatment of Patients With Metastatic Her-2 Positive Breast Cancer Status COMPLETED Phase PHASE2
NCT00192062 A Trial of Gemcitabine Combined With Vinorelbine as First Line Chemotherapy for Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT00176488 Epirubicin and Vinorelbine in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer Status TERMINATED Phase PHASE2
NCT00169104 Effects of Granulocyte Colony-stimulating Factor (G-CSF), Trastuzumab, and Vinorelbine on Immune Cell Function Status TERMINATED Phase PHASE2/PHASE3
NCT00151086 Oral Estramustine and Oral Vinorelbine in the Treatment of Hormone-Refractory Prostate Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00146549 Trastuzumab in Combination With Vinorelbine or Taxane-Based Chemotherapy in Patients With Metastatic Breast Cancer Status COMPLETED Phase PHASE3
NCT00140140 A Phase I/II Study of ABI-007 (Abraxane®, Nab®-Paclitaxel)and Vinorelbine in Patients With Stage IV (Metastatic) Breast Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT00134641 Study of Gemcitabine and Vinorelbine in Soft Tissue Sarcomas Status COMPLETED Phase PHASE2
NCT00130507 Benefit of Adding Trastuzumab to Second Line Chemotherapy in Breast Cancer Patients Previously Treated With Trastuzumab Status TERMINATED Phase PHASE2
NCT00128310 Vinorelbine Versus Gemcitabine Plus Vinorelbine in Metastatic Breast Cancer Patients Status COMPLETED Phase PHASE3